Two lines of painkillers are to be removed from the New Zealand market.
Paradex and Capadex contain the drug dextropropoxyphene.
Medsafe says it is pulling the medicines after a review into their safety and efficiency found their risks outweigh their benefits.
General manager Stewart Jessamine says the drugs will be
AdvertisementAdvertise with NZME.